The metabolic syndrome, by definition, is not a disease but is a clustering of individual
metabolic risk factors including abdominal obesity, hyperglycemia, hypertriglyceridemia …

strongly with insulin resistance. Excess upper body fat can accumulate either
intraperitoneally (visceral fat) or subcutaneously. Many investigators claim that excess …

Objective: Obesity is a major driver of cardiometabolic risk. Abdominal visceral adipose
tissue (VAT) and sc adipose tissue (SAT) may confer differential metabolic risk profiles. We …

Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de
criterios de intervención terapéutica - ScienceDirect Skip to main contentSkip to article Elsevier …

OBJECTIVE—To determine the prevalence of a metabolic syndrome phenotype among US
adolescents using the most recent national data and to examine trends in metabolic …

Background—To assess the utility of clinical definitions of the metabolic syndrome (MetS) to
identify individuals with increased cardiovascular risk, we examined the relation between …

La obesidad es una enfermedad crónica multifactorial fruto de la interacción entre genotipo
y ambiente. Esta enfermedad afecta a un gran porcentaje de la población de países …

Background: The interaction of the risk factors of abdominal obesity, disturbed glucose
homeostasis, dyslipidemia, and hypertension is believed to represent a distinct entity …

AIM: To assess the prevalence of Coronary Heart Disease (CHD) and Metabolic Syndrome
(MS) in patients treated with antipsychotics. METHODS: Retrospective, cross-sectional …

BACKGROUND: Different criteria have been proposed by the WHO, the ATPIII and the
International Diabetes Federation (IDF) for the diagnosis of the metabolic syndrome (MES) …